

> 定義 (Circ 2010;121:e266; Eur Heart J 2012;33:26)


# ACUTE AORTIC SYNDROMES

### 定義 (_Circ_ 2010;121:e266; _Eur Heart J_ 2012;33:26)

• **Aortic dissection:** intimal tear → blood extravasates into Ao media (creates false lumen)

• **Intramural hematoma** (IMH): vasa vasorum rupture → medial hemorrhage that does not communicate with aortic lumen; 6% of aortic syndromes; clinically managed as AoD

• **Penetrating ulcer:** atherosclerotic plaque penetrates elastic lamina → medial hemorrhage

### Classification (proximal twice as common as distal)

• **Proximal:** involves ascending Ao, regardless of origin (= Stanford A, DeBakey I & II)

• **Distal:** involves descending Ao only, distal to L subclavian art. (= Stanford B, DeBakey III)

### Risk factors (_Lancet_ 2015;385:800)

• **Classic** (in older 病人): **HTN** (h/o HTN in >70% of dissections); **age** (60s–70s), **sex** (~65% ♂); **smoking;** ↑ lipids. **Acute** ↑ **BP:** cocaine, Valsalva (eg, weightlifting).

• **Genetic or acquired predisposition:** _CTD_ (Marfan, Loeys-Dietz, Ehlers-Danlos type IV); _congenital anomaly_ (bicuspid AoV, coarct \[eg, Tuner’s syndrome\], PCKD); _aortitis_ (Takayasu’s, GCA, Behçet’s, syphilis); _preg._ (typically 3rd trim.); fluoroquinolone exposure

• **Trauma:** blunt, decel. injury (eg, MVA); IABP, cardiac/aortic surgery, Impella, cardiac cath

<table><colgroup><col> <col> <col></colgroup><tbody><tr><td colspan="3"><p><b>臨床表現 and Physical Exam<a id="st3"></a><a href="text/part0006_split_012.html#sst3">*</a></b> (<span><i>JAMA</i> 2000;283:897</span>)</p></td></tr><tr><td><p><b>Feature</b></p></td><td><p><b>Proximal</b></p></td><td><p><b>Distal</b></p></td></tr><tr><td><p><b>“Aortic” pain</b> (abrupt, severe, tearing or ripping quality, <i>maximal at onset</i> [vs. crescendo for ACS])</p></td><td><p><b>94%</b></p><p>(chest, back)</p></td><td><p><b>98%</b></p><p>(back, chest, abd)</p></td></tr><tr><td><p><b>Syncope</b> (often due to tamponade)</p></td><td><p><b>13%</b></p></td><td><p>4%</p></td></tr><tr><td><p><b>HF</b> (usually due to acute AI)</p></td><td><p><b>9%</b></p></td><td><p>3%</p></td></tr><tr><td><p><b>CVA</b></p></td><td><p><b>6%</b></p></td><td><p>2%</p></td></tr><tr><td><p><b>HTN</b></p></td><td><p>36%</p></td><td><p><b>70%</b></p></td></tr><tr><td><p><b>HoTN or shock</b> (tamponade, AI, MI, rupture)</p></td><td><p><b>25%</b></p></td><td><p>4%</p></td></tr><tr><td><p><b>Pulse deficit</b> (if involves carotid, subclavian, fem)</p></td><td><p><b>19%</b></p></td><td><p><b>9%</b></p></td></tr><tr><td><p><b>AI murmur</b></p></td><td><p><b>44%</b></p></td><td><p>12%</p></td></tr></tbody></table>

[\*](text/part0006_split_012.html#st3)S/S correlate with affected branch vessels & distal organs; may Δ as dissection progresses

### Initial evaluation & diagnostic studies (_Circ_ 2010;121:e266; _JACC CV Img_ 2014;7:406)

• H&P, incl. bilat BP & radial pulses for symmetry; ECG with STE if propagates to cor

• **CXR**: 異常 in 60–90% \[↑ mediast. (absence ⊖ LR 0.3), L pl effusion\] but _cannot_ 排除 AoD

• **CT:** quick and available, Se ≥93%, Sp 98%; facilitates “triple rule-out” ACS vs. PE vs. AoD

• **MRI:** Se & Sp >98%, but time-consuming test & not readily available

• **TEE:** Se >95% prox, 80% for distal; can assess cors/peric/AI; “blind spot” behind trachea

• ⊖ Initial imaging but high 臨床suspicion → further studies (2/3 with AoD have ≥2 studies)

• **D-dimer** <500 ng/mL has Se/NPV ~97%, Sp ~50%, _but not if high risk_ and not for IMH

• ? risk score (0–3 points): high-risk (eg, genetics, recent Ao manip); aortic pain; e/o perfusion deficit, AI or shock. Score >1 → imaging; ≤1 & DD <500 has NPV >99% (_Circ_ 2018;137:250)

### 治療 (_Circ_ 2010;121:1544; _JACC_ 2013;61:1661; _Lancet_ 2015;385:800)

• ↓ **dP/dt** targeting HR <60 & central BP <120 (or lowest that preserves perfusion; 排除 pseudohypotension, eg, arm BP ↓ due to subclavian dissection; use highest BP reading)

• **_First_ IV βB** (eg, esmolol, labetalol) to blunt reflex ↑ HR & inotropy in response to vasodilators; verap/dilt if **β**B contraindic; **_then_** ↓ **_SBP with_ IV vasodilators** (eg, nitroprusside)

• **If HoTN:** urgent surgical consult, IVF to achieve euvolemia, pressors to keep (MAP 70 mmHg); 排除 complication (eg, tamponade, contained rupture, severe AI)

• **Proximal:** surgery considered in **all acute** and in chronic if c/b progression, AI or aneurysm

• **Distal:** med Rx unless complication (see below), however pre-emptive endovascular intervention may ↓ late complications, mort (_JACC_ 2013;61:1661; _Circ Cardiovasc Int_ 2013;6:407)

### Complications (occur in ~20%; _Circ_ 2010;121:e266; _Lancet_ 2015;385:800)

• _Freq assess (sx, BP, UOP), pulses, labs (Cr, Hb, lactic acid), imaging (~7 d or sooner if_ ∆_s)_

• _Uncontrolled BP or persistent pain may indicate complication/extension_

• **Progression:** propagation of dissection, ↑ aneurysm size, ↑ false lumen size

• **Rupture:** pericardial sac → tamponade (avoid pericardiocentesis unless PEA); blood in pleural space, mediast., retroperitoneum; ↑ in hematoma on imaging portends rupture

• **Malperfusion** (partial or complete obstruction of branch artery) _coronary_ → MI (usually RCA → IMI b/c dissection follows outer Ao curvature); _innominate/carotid_ → CVA, Horner; _intercostal/lumbar_ → spinal cord ischemia/paraplegia; _innominate/subclavian_ → upper ext ischemia; _iliac_ → lower ext ischemia; _celiac/mesenteric_ → bowel ischemia; _renal_ → AKI or slow ↑ Cr, refractory HTN

• **AI:** due to annular dilatation or disruption or displacement of leaflet by false lumen

• Mortality: ~1%/h × 48 h for acute prox AoD with 10–35% at 30 d; ↑ mort. if HTN or HoTN

• **Long-term serial imaging** (CT or MRI; ↓ rad with MRI) at 1, 3, and 6 mo, and then annually
